- Home
- SSTK vs CRMD Comparison
SSTK vs CRMD Comparison
Compare SSTK & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SSTK | CRMD |
|---|---|---|
| Founded | 2003 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 570.9M | 590.7M |
| IPO Year | 2012 | 2009 |
Fundamental Metrics
Financial Performance| Metric | SSTK | CRMD |
|---|---|---|
| Price | $4.13 | $7.54 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $15.33 |
| AVG Volume (30 Days) | ★ 818.0K | 787.9K |
| Earning Date | 11-04-2026 | 11-11-2026 |
| Dividend Yield | ★ 24.14% | N/A |
| EPS Growth | 23.76 | ★ 780.00 |
| EPS | N/A | ★ 0.72 |
| Revenue | N/A | ★ $311,709,000.00 |
| Revenue This Year | N/A | $8.13 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $10.28 |
| Revenue Growth | N/A | ★ 617.03 |
| 52 Week Low | $3.76 | $6.13 |
| 52 Week High | $29.50 | $13.02 |
Technical Indicators
Market Signals| Indicator | SSTK | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 38.93 | 45.42 |
| Support Level | $3.76 | $7.50 |
| Resistance Level | $6.10 | $9.01 |
| Average True Range (ATR) | 0.26 | 0.24 |
| MACD | 0.08 | -0.01 |
| Stochastic Oscillator | 46.30 | 42.48 |
Price Performance
Historical ComparisonAbout SSTK Shutterstock Inc.
Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market, but also has its presence in Europe and Rest of the Countries.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.